Health TrialsbyHealthPanel

Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation

ConditionsAcute Coronary SyndromeMyocardium; Injury
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

AMIPE is both a retrospective and prospective study which was designed in order to collect data of patients with acute coronary syndromes and myocardial injury and to improve the knowledge about these conditions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient aged > 18 years old

Acute coronary syndrome or myocardial injury

Written informed consent

Disqualifiers

under age or not able to give informed consent

Trial population

Patients admitted with a diagnosis of acute coronary syndrome or myocardial injury

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Database

    Other intervention

    Create a database containing clinical characteristic, clinical presentation, flow indexes and treatment of consecutive incident patients with ACS or myocardial injury.

Treatment groups

11,000 Participants
are divided into 1 treatment group
Group A: Patients with acute coronary syndrome or myocardial injury1 intervention

Trial outcomes

Primary outcomes

1

All cause mortality

Death rate

Time frame
1 year
2

All cause mortality

Death rate

Time frame
3 years
3

All cause mortality

Death rate

Time frame
5 years
4

Major Adverse Cardiac Events (MACEs)

MACEs rate

Time frame
1 year

Secondary outcomes

1

Cardiovascular risk factors prevalence

Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors

Time frame
1 year
2

Cardiovascular risk factors prevalence

Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors

Time frame
3 year
3

Cardiovascular risk factors prevalence

Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors

Time frame
5 year
4

Differences in clinical presentation

Prevalence of patients presenting with ST elevation, angina, dyspnea, atypical chest pain, cardiogenic shock, arrhytmias)

Time frame
3 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov
Apply now